Advertisement

Atypical Lobular Hyperplasia and Lobular Carcinoma In Situ

  • Isabel Alvarado-Cabrero
Chapter

Abstract

Despite the earlier description by Ewing [1], the term lobular carcinoma is largely credited to Foote and Stewart [2] who, in 1941, published their seminal paper describing a detailed morphologic analysis of a distinctive subgroup of in situ carcinoma of the breast. Almost 40 years after the first description of lobular carcinoma in situ (LCIS), Haagensen et al. [3] published their own experience with this disease and concluded that “lobular neoplasia” was a more appropriate term for this lesion, as few cases appeared to progress to invasive carcinoma. With increasing recognition of LCIS, it became apparent that less well-developed forms were more frequently seen in the breast. Page et al. [4] used the term atypical lobular hyperplasia for these lesions.

Keywords

Atypical lobular hyperplasia Lobular carcinoma in situ Morphological features 

References

  1. 1.
    Ewing J. Neoplastic diseases: a textbook on tumors. 1st ed. Philadelphia, PA: WB Saunders; 1919.Google Scholar
  2. 2.
    Foote F, Stewart F. Lobular carcinoma in situ: a rare form of mammary cancer. Am J Pathol. 1941;17:491–6.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Haagensen CD, Lane N, Lattes R, Bodian C. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer. 1978;42:737–69.CrossRefGoogle Scholar
  4. 4.
    Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer. 1985;55:2698–708.CrossRefGoogle Scholar
  5. 5.
    Bratthauer GL, Tavassoli FA. Lobular intraepithelial neoplasia: previously unexplored aspects assessed in 775 cases and their clinical implications. Virchows Arch. 2002;440:134–8.CrossRefGoogle Scholar
  6. 6.
    Chickman B, Lavy R, Davidson T, Wassermann I, Sandbank J, Siegelmann-Danieli N, et al. Factors affecting rise in the incidence of infiltrating lobular carcinoma of the breast. Isr Med Assoc J. 2010;12:697–700.Google Scholar
  7. 7.
    Li CI, Anderson BO, Daling JR, Moe RE. Changing incidence of lobular carcinoma in situ of the breast. Breast Cancer Res Treat. 2002;75:259–68.CrossRefGoogle Scholar
  8. 8.
    Malley FO. Lobular neoplasia: morphology, biological potential and management in core biopsies. Mod Pathol. 2010;23(Suppl 2):S14–25.CrossRefGoogle Scholar
  9. 9.
    Middleton LP, Grant S, Stephens T, Stelling CB, Sneige N, Sahin AA. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised? Mod Pathol. 2003;16:120–9.CrossRefGoogle Scholar
  10. 10.
    Bodian CA, Perzin KH, Lattes R. Lobular neoplasia. Long term risk of breast cancer and relation to other factors. Cancer. 1996;78:1024–34.CrossRefGoogle Scholar
  11. 11.
    Lakhani SR. In situ lobular neoplasia: time for an awakening. Lancet. 2003;361:96.CrossRefGoogle Scholar
  12. 12.
    Fadare O, Dadmanesh F, Alvarado-Cabrero I, Snyder R, Stephen Mitchell J, Tot T, et al. Lobular Intraepithelial (lobular carcinoma in situ) with comedo-type necrosis: a clinico-pathologic study of 18 cases. Am J Surg Pathol. 2006;30:1445–53.CrossRefGoogle Scholar
  13. 13.
    Alvarado-Cabrero I, Picón Coronel G, Valencia Cedillo R, Canedo N, Tavassoli FA. Florid lobular intraepithelial neoplasia with signet ring cells, central necrosis and calcifications: a clinicopathological and immunohistochemical analysis of ten cases associated with invasive lobular carcinoma. Arch Med Res. 2010;41:436–41.CrossRefGoogle Scholar
  14. 14.
    Bentz JS, Yassa N, Clayton F. Pleomorphic lobular carcinoma of the breast: clinicopathologic features of 12 cases. Mod Pathol. 1998;11:814–22.PubMedGoogle Scholar
  15. 15.
    Dabbs DJ, Kaplai M, Chivukula M, Kanbour A, Kanbour-Shakir A, Carter GJ. The spectrum of morphomolecular abnormalities of the E-cadherin/catenin complex in pleomorphic lobular carcinoma of the breast. Appl Immunohistochem Mol Morphol. 2007;15:260–6.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Isabel Alvarado-Cabrero
    • 1
  1. 1.Department of Pathology, Hospital de Oncologia, Centro Medico Nacional Siglo XXIInstituto Mexicano del Seguro SocialMexico CityMexico

Personalised recommendations